Recent News

By Category: Research

Bacillus ACT 2013 – International Anthrax Conference

Scientists and researchers from all over the world who work on Bacillus anthracis, the causative agent of anthrax, and B. cereus and B. thuringiensis, two closely related bacilli, will be heading to Victoria, British Columbia in September. The main mission of the Bacillus ACT … Continue reading →

April 12, 2013
| Filed under Research
Share

Bacillus ACT 2013 – International Anthrax Conference

April 12, 2013
| Filed under Research
Share

Scientists use nature against nature to develop an antibiotic with reduced resistance

(EurekAlert) A new broad range antibiotic, developed jointly by scientists at The Rockefeller University and Astex Pharmaceuticals, has been found to kill a wide range of bacteria, including drug-resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs, in mice. The antibiotic, Epimerox, targets weaknesses in bacteria that have long been exploited by viruses Read More »

April 11, 2013
| Filed under North America and Research
Share

War With North Korea Smallpox and Bioweapons Are the Real Threat Not Nukes

(PolicyMic) The good news is, despite threats last week that American targets would be “reduced to ashes and flames the moment the first attack is unleashed,” it is doubtful that North Korea can strike the United States with a missile. We should be safe from their nukes, at least as long as they don’t atomize Read More »

April 11, 2013
| Filed under Asia/Pacific and Research
Share

Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology

(EurekAlert) Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true. On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today’s front-line antimalaria drug, based Read More »